|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Nov 30, 2024
|
Q3 FY2024
As of Aug 31, 2024
|
Q2 FY2024
As of May 31, 2024
|
Q1 FY2024
As of Feb 29, 2024
|
Q4 FY2023
As of Nov 30, 2023
|
Q3 FY2023
As of Aug 31, 2023
|
Q2 FY2023
As of May 31, 2023
|
Q1 FY2023
As of Feb 28, 2023
|
Q4 FY2022
As of Nov 30, 2022
|
Q3 FY2022
As of Aug 31, 2022
|
Q2 FY2022
As of May 31, 2022
|
Q1 FY2022
As of Feb 28, 2022
|
Q4 FY2021
As of Nov 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||||||
| Loan payable - related party | |||||||||||||||||||
| Other receivable and prepayment | |||||||||||||||||||
| Fund held in trust | |||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||
| Accounts receivable | |||||||||||||||||||
| Other receivable | |||||||||||||||||||
| Prepaid expense | |||||||||||||||||||
| Prepaid | |||||||||||||||||||
| Due from related party | |||||||||||||||||||
| Deferred share issuance cost | |||||||||||||||||||
| Total Current Assets | |||||||||||||||||||
| Other Assets | |||||||||||||||||||
| Intangible assets, net | |||||||||||||||||||
| Prepaid expense | |||||||||||||||||||
| Total Other Assets | |||||||||||||||||||
| Goodwill | |||||||||||||||||||
| Property and Equipment, net | |||||||||||||||||||
| Intangible assets, net | |||||||||||||||||||
| Property and Equipment, net | |||||||||||||||||||
| Total Assets | |||||||||||||||||||
| Current Liabilities | |||||||||||||||||||
| Accounts payable | |||||||||||||||||||
| Accounts payable and accrued liabilities | |||||||||||||||||||
| Accrued interest | |||||||||||||||||||
| Due to related parties | |||||||||||||||||||
| Convertible notes payable | |||||||||||||||||||
| Derivative Liabilities | |||||||||||||||||||
| Stock payable | |||||||||||||||||||
| Total Current Liabilities | |||||||||||||||||||
| Loan payable – related party | |||||||||||||||||||
| Total Long-Term Liabilities | |||||||||||||||||||
| Contingent liability | |||||||||||||||||||
| Loan payable | |||||||||||||||||||
| Total Liabilities | |||||||||||||||||||
| Preferred Stock, par value $0.001, 100,000,000 shares authorized, 0 shares issued and outstanding, respectively | |||||||||||||||||||
| Common Stock: $0.001 par value, 1,000,000,000 shares authorized, 80,349,992 shares and 61,254,427 shares issued and outstanding, respectively | |||||||||||||||||||
| Additional paid-in capital | |||||||||||||||||||
| Accumulated deficit | |||||||||||||||||||
| Accumulated other comprehensive income | |||||||||||||||||||
| Less: Deferred compensation (including $23,795 and $34,890 of deferred compensation to related party, respectively) | |||||||||||||||||||
| Less: Deferred compensation (including $12,575 and $34,890 of deferred compensation to related party, respectively) | |||||||||||||||||||
| Less: Treasury Stock | |||||||||||||||||||
| Total deficit attributed to Transuite.Org. Inc. | |||||||||||||||||||
| Non-controlling interest | |||||||||||||||||||
| Total Stockholders' Deficit | |||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | |||||||||||||||||||
Loading...
